Last edition
News about Biotechnology
The European Commission has granted Orphan Medicinal Product Designation in the EU for MIV-818
Medivir today announced that the European Commission, in accordance with the opinion from the European Medicines Agency (EMA), has granted orphan medicinal product designation in the EU for MIV-818 for the treatment of patients with hepatocellular carcinoma (HCC), the most common type of primary liver cancer
Biotechnology | 05/07/2020 | By Darshana | 443
NPPA fixes retail prices of 14 formulations under DPCO 2013
NPPA has fixed retail prices of 14 formulations under Drugs Prices Control Order (DPCO)- 2013 relating to 76th Authority meeting dated June 22, 2020.
Biotechnology | 03/07/2020 | By Darshana | 809
Selumetinib granted orphan drug designation in Japan for neurofibromatosis type 1
AstraZeneca today announced that selumetinib has been granted orphan drug designation (ODD) in Japan for the treatment of neurofibromatosis type 1 (NF1), a rare and debilitating genetic disease
Biotechnology | 01/07/2020 | By Darshana | 428
'COVAXIN': India's first Covid vaccine gets DGCI's approval for clinical trials
Bharat Biotech, has successfully developed Covaxin, India's 1st vaccine candidate for COVID-19, in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech
Biotechnology | 30/06/2020 | By Darshana | 353
Hetero Healthcare set to supply 20,000 vials of generic remdesivir across country
Following the approval of "Covifor", the generic of remdesivir by DCGI, Hetero Healthcare Limited, a group company of Hetero is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each
Biotechnology | 25/06/2020 | By Darshana | 497
Novartis discontinues hydroxychloroquine trial for COVID-19 due to acute enrollment challenges
Novartis has made the decision to stop and discontinue its sponsored hydroxychloroquine(HCQ) clinical trial for COVID-19 due to acute enrollment challenges that have made trial completion infeasible
Biotechnology | 22/06/2020 | By Darshana | 280
Merck Animal Health, known as MSD Animal Health outside the United States and Canada, announced the completion of its acquisition of Quantified Ag, a leading data and analytics company that monitors cattle body temperature and movement in order to detect illness early
Biotechnology | 19/06/2020 | By Darshana | 367
Neurocrine Biosciences Inc and Takeda Pharmaceutical Company Limited announced a strategic collaboration to develop and commercialise compounds in Takeda's early-to-mid-stage psychiatry pipeline. Specifically, Takeda granted an exclusive license to Neurocrine Biosciences for seven pipeline programmes, including three clinical stage assets
Biotechnology | 18/06/2020 | By Darshana | 242
Bayer announced today the initiation of the FINEARTS-HF study, a multicenter, randomized, double-blind, placebo-controlled Phase III study to evaluate the efficacy and safety of finerenone on morbidity and mortality in patients suffering from symptomatic heart failure
Biotechnology | 16/06/2020 | By Darshana | 606
Following National Pharmaceutical Pricing Authority (NPPA) directive to address the demand of tocilizumab injection in government hospitals in Gujarat for the treatment of COVID-19 patients, the Mumbai-based pharmaceutical major Cipla Ltd has renewed its supply by releasing another batch of 700 tocilizumab injections to Gujarat
Biotechnology | 11/06/2020 | By Darshana | 1015
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy